TDC
20
-13
CI
58
-12
ADSK
52
3
PBI
40
-12
NOC
45
-2
DRI
70
-2
LLY
59
2
MLM
51
-2
MPC
42
-2
JCI
54
3
SIG
60
3
INTU
65
8
R
61
2
HSIC
54
-2
ETR
63
-2
BRK.B
49
-3
WM
71
-3
BLK
64
-2
CB
44
-3
EXR
40
-6
TDC
20
-13
CI
58
-12
ADSK
52
3
PBI
40
-12
NOC
45
-2
DRI
70
-2
LLY
59
2
MLM
51
-2
MPC
42
-2
JCI
54
3
SIG
60
3
INTU
65
8
R
61
2
HSIC
54
-2
ETR
63
-2
BRK.B
49
-3
WM
71
-3
BLK
64
-2
CB
44
-3
EXR
40
-6
Financhill
Back

Verisk Analytics Vs. Ascendis Pharma AS Industry Stock Comparison

Buy
59

VRSK
Verisk Analytics

Last Price:
$285.13
Seasonality Move:
5.59%
Sell
45

ASND
Ascendis Pharma AS

Last Price:
$166.13
Seasonality Move:
-5%
Buy
59
Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

  • The current Verisk Analytics [VRSK] share price is $285.16. The Score for VRSK is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • VRSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $165.99. The Score for ASND is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

  • The Verisk Analytics share price today is $285.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight selling pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $165.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.

VRSK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 41.56 Sell
Chaikin Money Flow: -68709 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (288.66 - 297.46) Sell
Bollinger Bands (100): (275.71 - 293.25) Buy

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.67 Buy
Relative Strength Index (14 RSI): 63.29 Buy
Chaikin Money Flow: 106793 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.54 - 162) Buy
Bollinger Bands (100): (124.23 - 147.87) Buy

VRSK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 288.58 Sell
20-day SMA: 292.77 Sell
50-day SMA: 287.85 Sell
200-day SMA: 276.79 Buy
8-day EMA: 289.03 Sell
20-day EMA: 290.89 Sell
50-day EMA: 288.85 Sell
200-day EMA: 274.89 Buy

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 160.55 Buy
20-day SMA: 155.39 Buy
50-day SMA: 140.97 Buy
200-day SMA: 135.15 Buy
8-day EMA: 161.32 Buy
20-day EMA: 154.72 Buy
50-day EMA: 145.66 Buy
200-day EMA: 135.84 Buy

Verisk Analytics Earnings Growth & VRSK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.81 per share, an increase next quarter of $0.04 per share, an increase this year of $3.20 per share, and an increase next year of $5.33 per share.

Verisk Analytics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):